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Abstract 
Background: Chronic kidney disease (CKD) is an important health problem for which risk 
equations have been developed for Western populations. This study aimed to develop and 
validate a risk prediction equation for CKD in a Japanese population. 
Study Design: Observational cohort study. 
Setting & Participants: The study included 135 007 participants who completed an annual 
health check-up between 1993 and 1996 in the Ibaraki Prefecture in Japan. Participants were 
initially free of CKD stage 3, 4 or 5, and proteinuria 2+ or 3+. Follow-up information was 
available from health check-ups 10 years after initial evaluation. We used data from 17 892 
men and 40 963 women in the northern region of the prefecture for the development of risk 
prediction equations, and 22 992 men and 49 952 women in the southern region for external 
validation. 
Predictors: Age, estimated glomerular filtration rate (eGFR), body mass index, proteinuria, 
hematuria, hypertension, diabetes mellitus, smoking, and drinking.  
Outcome: Occurrence of eGFR <60 mL/min/1.73 m2 and/or proteinuria 2+ or 3+. 
Analytical Approach: Logistic regression analysis to estimate risk for CKD stratified by 
sex. 
Results: During follow-up, 7500 cases of CKD developed in the northern region and 8964 in 
the southern region. Older age, proteinuria(+), higher systolic blood pressure, medication for 
hypertension, and current smoking were associated with the risk of CKD in both sexes while 
higher eGFR and daily alcohol intake were associated with lower risk. C-statistics of the risk 
estimation equations for CKD at 10 years were >0.8 for both the development and external 
validation populations, and discrimination of the risk estimation was fairly good in men and 
women. 
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Limitations: Fluctuations in variables were not evaluated because the study used annual 
health check-ups. This study excluded a large number of people for whom a 10-year health 
check-up was not available. 
Conclusions: Estimations of risk for CKD after 10 years of follow-up in a general Japanese 
population can be achieved with a high level of validity. 
Index words: estimated glomerular filtration rate, chronic kidney disease, risk score, 
Japanese, Asian, cohort study 
Summary of article: Chronic kidney disease (CKD) is an important health problem. A risk 
estimation tool (risk score for CKD prevention) has been developed for Western populations, 
but not Asian populations. This study aimed to develop and validate prediction equations for 
CKD at 10 years in a Japanese population. We included 135 007 Japanese people who had 
completed annual health check-ups between 1993 and 1996. Participants were free from 
CKD (defined as CKD stage 3 or higher and/or proteinuria 2+ or 3+) and/or renal disease, 
and information was available from their health check-ups 10 years later. We included 58 855 
people living in the northern region for development of prediction equations. The remaining 
participants were included in the external validation. The discrimination of the risk prediction 
equations was fairly good in men and women. The c-statistics for external validation were 
>0.8.
5 
Introduction 
Chronic kidney disease (CKD) is one of the most common non-communicable diseases. CKD 
is associated with the risk for end-stage renal disease (ESRD), mortality from cardiovascular 
disease (CVD), and mortality from any causes (1). Prevention of CKD is important, but it is 
difficult to identify patients with early stage CKD because it is asymptomatic. 
A risk prediction tool such as risk score is useful to evaluate whether people are at 
high risk for developing chronic diseases. For example, there are several risk scores for 
coronary heart disease and CVD (2, 3). For CKD, a major risk score for Western populations 
was developed from the results of the Framingham Heart Study and Atherosclerosis Risk in 
Communities (4). However, in Asian populations, there are only a few prospective studies of 
Japanese people that have examined the association between risk factors and the risk for 
CKD (5, 6), and a risk prediction tool for CKD for Asian general populations has not been 
developed. 
According to the Japanese Society of Nephrology, the prevalence of CKD in Japanese 
adults is approximately 20% (7). This number is expected to increase because of the aging 
Japanese population. Therefore, it is important to develop a useful risk prediction tool to 
detect people at high risk for CKD. 
The aim of this study was to develop and validate risk prediction equations for CKD 
using those factors generally measured at annual health check-ups in Japan. A predictive tool 
based on data collected from the general population may be useful in both public health and 
medical settings. 
 
Methods 
Study participants 
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Participants were Japanese people aged 40–74 years old who were living in Ibaraki 
Prefecture. A baseline survey was conducted between 1993 and 1996 during which time a 
total of 307 531 people (105 381 men and 202 150 women) attended annual health check-ups. 
Of these, 141 608 also attended an annual health check-up 10 years later. We included 135 
007 people (41 002 men and 94 005 women) because they had completed the examination 
and were free from renal disease or CKD at the first check-up. We defined CKD as estimated 
glomerular filtration rate (eGFR) <60 mL/min/1.73 m2 and/or proteinuria 2+ or 3+. 
Of the 135 007 participants included, we used data from 58 855 people (17 892 men 
and 40 963 women) living in the northern region of Ibaraki Prefecture for the development of 
the risk prediction equations. For validation of the risk prediction equations, we used data 
from 76 152 people (23 110 men and 53 042 women) living in the southern region of Ibaraki 
Prefecture for external validation. 
Informed consent was obtained from community representatives to conduct an 
epidemiological study on the basis of the guidelines of the Council for International 
Organizations of Medical Science. The study was approved by the Ethics Committee of 
Ibaraki Prefecture. 
Risk factor survey 
The annual health check-up was performed by the Ibaraki Health Service Association. Health 
check-ups conducted between 1993 and 1996 were regarded as the baseline survey. Health 
check-ups conducted 10 years after the baseline survey were regarded as the follow-up 
survey. If a person had undergone an annual health check-up twice or more between 1993 
and 1996, the earliest data was used for the analyses. The check-up consisted of body weight 
measurement with light clothing, medical history, alcohol/smoking status, blood pressure 
measurement, blood tests, and dipstick urine tests. Serum creatinine was measured using the 
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modified Jaffe method until March 2004 and using the enzymatic method from April 2004 
with an autoanalyzer (Hitachi 7350; Hitachi, Tokyo, Japan or RX-20; JEOL, Tokyo, Japan). 
The following formula was used to calculate the creatinine value based on the Jaffe method 
value and the enzymatic method value: serum creatinine (enzymatic method) = 1.0085 × 
creatinine (Jaffe method) − 0.265 mg/dL. The creatinine values reported in this study 
represent the calculated enzymatic values. eGFR was calculated using the following formula 
established by the working group of the Japanese Chronic Kidney Disease Initiative: eGFR 
(mL/min/1.73 m2) = 1.94 × (serum creatinine)−1.094 × (age)−0.287 × 0.739 (if female) (8). Blood 
glucose was measured using the autoanalyzer. Proteinuria and hematuria were tested with 
dipsticks (Ames Hemacombisticks; Bayer-Sankyo, Tokyo, Japan). Blood pressure was 
measured using standard mercury sphygmomanometers or automated sphygmomanometers 
on the right arm. If blood pressure was high with the first measurement, the blood pressure 
measurement was repeated once. 
 
Statistical analysis 
Multivariable logistic regression models were used to evaluate risk factors for CKD. 
Regression coefficients, odds ratios (OR), and their 95% confidence intervals were calculated 
after adjustment for age and risk factors. The risk factors were eGFR (mL/min/1.73 m2), 
dipstick proteinuria (+ and missing), dipstick hematuria (+, 2+, 3+, and missing), body mass 
index (kg/m2), systolic blood pressure (mmHg), medication for hypertension, medication for 
diabetes mellitus, smoking status (past smoker and current smoker), and alcohol intake 
(occasional and every day). We also included glucose tolerance as a risk factor. Fasting status 
was self-reported and the oral glucose tolerance testing was not performed. We used fasting 
serum glucose (mg/dL) or non-fasting serum glucose (mg/dL) for the index of glucose 
tolerance. For proteinuria, hematuria, medication for hypertension, medication for diabetes 
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mellitus, and smoking and alcohol intake, we used participants who did not have the risk 
factor as the reference. For systolic blood pressure and glucose tolerance, if measurements 
were not taken for a participant, it was regarded as missing. 
Two models were developed for the risk prediction equations. The simple risk 
prediction equation included age, eGFR, proteinuria, and hematuria. The full risk prediction 
equation included age, eGFR, proteinuria, hematuria, body mass index, systolic blood 
pressure, medication for hypertension, glucose tolerance, medication for diabetes mellitus, 
and smoking and alcohol intake. The risk predicted equations for the logistic model were 
based on the formula: p
^
 = 1 / (1 + exp( − (intercept + sum of the estimate per risk factors)). 
The estimate of each risk factor was calculated as: (regression coefficient) × (value of each 
factor). We used risk factors that were significantly associated with the risk for CKD at 10 
years for calculation of the risk estimate. We developed a calibration plot for each model to 
examine the discrimination among risk scores (Figures 1 and 2). We also calculated the 
c-statistic for each model to validate the risk prediction equations for CKD at 10 years. Risk 
scores were calculated using the Framingham Study risk score functions (9). The following 
classifications were used. eGFR: 60–74, 75–89, 90–119, or ≥120 mL/min/1.73 m2. Blood 
pressure: stage 1 hypertension: 140 mmHg ≤ systolic blood pressure < 160 mmHg and/or 90 
mmHg ≤ diastolic blood pressure < 100 mmHg; stage 2 hypertension: 160 mmHg ≤ systolic 
blood pressure < 180 mmHg and/or 100 mmHg ≤ diastolic blood pressure < 110 mmHg; 
stage 3 hypertension: 180 mmHg ≤ systolic blood pressure and/or 110 mmHg ≤ diastolic 
blood pressure, medicated and missing. Glucose tolerance: impaired glucose tolerance: 110 
mg/dL ≤ fasting serum glucose < 126 mg/dL or 140 mg/dL ≤ non-fasting serum glucose < 
200 mg/dL. Diabetes: 126 mg/dL ≤ fasting serum glucose or 200 mg/dL ≤ non-fasting serum 
glucose, medicated and missing. These classifications were used instead of continuous 
variables to simplify the calculations. We excluded body mass index from risk score because 
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body mass index was not significantly associated with the risk of CKD at 10 years in this 
analysis. The methods for how the risk scores were determined are provided in Supplemental 
Table 1. We determined 1 point as the risk associated with a 5-year increase in age. We 
defined the constant as: the estimate per 1-year increment of the regression coefficients of the 
multiple regression model multiplied by 5. We determined points associated with each 
category by dividing the estimate of each risk factor by the constant. The points of each risk 
factor were rounded to the nearest integer. Estimated risk for CKD associated with point 
totals was based on the Framingham Study risk score functions (9). For Model 1 (simple risk 
score), risk score comprised age, proteinuria, hematuria, and baseline eGFR. For Model 2 
(full risk score), risk score comprised the variables in Model 1 plus blood pressure, glucose 
tolerance, smoking status, and drinking status. Estimated risk for CKD was calculated as: 1 / 
(1 + exp(4.1537 − 0.268 × points)) for men and 1 / (1 + exp(3.7942 − 0.121 × points)) for 
women in Model 1; and 1 / (1 + exp(4.2248 − 0.257 × points)) for men and 1 / (1 + 
exp(3.8008 − 0.1055 × points)) for women in Model 2. SAS software (ver. 9.4; SAS Institute 
Inc., Cary, NC, USA) was used for all analyses. A P-value <0.05 was considered statistically 
significant (two-tailed analysis). 
 
Results 
Table 1 shows the characteristics of participants stratified by geographic area. During the 
10-year follow-up, a total of 16 464 people developed CKD. In the northern region, 2840 
men and 4660 women developed CKD, and in the southern region, 3266 men and 5698 
women developed CKD. 
Table 2 and 3 shows the regression coefficients and the multivariable-adjusted OR for 
CKD at 10 years among people living in the northern region.  
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For Model 1, age at baseline and proteinuria (+) were positively, and eGFR was 
negatively, associated with the risk for CKD in men and women. Weak (+) hematuria was 
positively associated with the risk for CKD in men but not in women, while severe (3+) 
hematuria was positively associated with the risk for CKD in women but not in men. 
For Model 2, associations between risk factors included in Model 1 and the risk for 
CKD was consistent. Systolic blood pressure, medication for hypertension, and current 
smoker were positively associated with the risk for CKD in both men and women. Fasting 
serum glucose, non-fasting serum glucose, and daily alcohol intake were negatively 
associated with the risk for CKD in both men and women. Body mass index was positively, 
and past smoking was negatively associated with the risk for CKD in men but not women. 
Medication for diabetes mellitus was positively, and occasional alcohol intake was negatively, 
associated with the risk for CKD in women but not men. According to these results, we 
developed risk predictive equations both simple and full model (Table 4). 
Figure 1 shows the calibration plot for each model in men. The discrimination of the 
prediction equations were fairly good until 70% of predicted probabilities. Figure 2 shows the 
calibration plot for each model in women. The discrimination of prediction equations were 
fairly good until 60% of predicted probabilities. 
We also calculated the c-statistics for each risk prediction equation. For Model 1, the 
c-statistic of the 10-year risk for CKD in people living in the southern region (for external 
validity) was 0.827 for men and 0.814 for women. For people living in the northern region 
(for develpoment), the c-statistic was 0.823 for men and 0.824 for women. For Model 2, the 
c-statistic was 0.831 and 0.815 for men and women living in the southern region and 0.827 
and 0.826 for men and women living in the northern region, respectively. 
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Based on these results, we developed the risk score for each category of risk factors 
for CKD at 10 years (Table S2). The estimated risk for CKD at 10 years is shown in 
Supplemental Table 3, according to the developed risk score. 
Discussion 
We developed and validated risk prediction equations for CKD at 10 years based on annual 
health check-ups among a Japanese general population. The risk prediction equations showed 
good validity for both the development and external validation. According to the risk 
estimates, baseline eGFR value was the most important predictor of CKD at 10 years, and 
dipstick proteinuria was the second most important predictor. 
In the current study, the association between diabetes mellitus and the risk for CKD 
was different from some prior studies (4, 10-12). Fasting serum glucose and non-fasting 
serum glucose were negatively associated with the risk for CKD at 10 years, while 
medication for diabetes mellitus was positively associated with the risk for CKD at 10 years 
in women. In the additional analysis (Table S4), impaired glucose tolerance was negatively 
associated, and diabetes mellitus without medication was not associated, with the risk for 
CKD at 10 years. We suggest that the differences between the previous studies and the 
current study are related to the progressive nature of CKD in patients with diabetes (13). In 
general, the eGFR of patients with diabetes often remains stable or even reaches 
hyperfiltration in 10–15 years. Therefore, we suspect that the lack of association between 
non-medicated diabetes mellitus or impaired glucose tolerance with elevated risk for CKD in 
this cohort of Japanese participants is because diabetic renal injury first manifests as 
hyperfiltration before loss of eGFR becomes evident. 
In the current study, we included dipstick hematuria and smoking and alcohol intake 
as potential risk factors, although they were not used in the risk score for the Western 
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population (4), because previous epidemiological studies have reported an association 
between those factors and the risk for CKD or ESRD (5, 6, 12, 14). For hematuria, a 
prospective study of Japanese people reported a positive association between hematuria and 
the risk for CKD (5). In the study, weak (+) hematuria and moderate to severe (2+ and 3+) 
hematuria were positively associated with the risk for CKD stage 3 or higher. A prospective 
study of Israeli men and women reported that microscopic hematuria was positively 
associated with the risk for ESRD (14). In the current study, the association between dipstick 
hematuria and the risk for CKD was inconsistent between men and women. Regarding 
smoking, previous epidemiological studies report a positive association between smoking and 
the risk for CKD (12, 15), which is consistent with our results. A prospective study of 
Australian men and women reported an inverse association between alcohol intake and the 
risk for CKD (16), while another prospective study of American men and women reported a 
positive association between frequent or heavy alcohol intake and the risk for CKD (15). In 
the current study, daily alcohol intake was inversely associated with the risk for CKD in both 
men and women. 
The strengths of the current study include the study design and the participants. We 
used a prospective cohort design with a large number of Japanese participants from the 
general population. This allowed us to develop and validate risk prediction equations that 
included many risk factors, which should help physicians evaluate the estimated risk for CKD 
in their patients. In addition, we developed CKD risk prediction equations using variables 
whose measurements are not expensive or difficult, meaning the prediction equations and risk 
score can be widely used. Evaluation of CKD risk in a health survey is beneficial for the 
detection of high risk CKD populations, and would allow for early intervention to prevent 
CKD progression.  
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This study had some limitations. First, the study was based on annual health 
check-ups. Examinations performed once a year do not allow for the evaluation of any 
fluctuation in serum creatinine and other variables. However, any errors concerning the 
misclassification were non-differential. Second, a large number of people were excluded 
from the analysis. The main reason for exclusion was that they did not attend an annual 
health check-up 10 years after the first. We did not have information for why they did not 
attend the health check-up; however, compared with people who attended the 10-year annual 
health check-up, people who did not attend were almost 3.6 years older for men and 4.4 years 
older for women at the baseline survey. Also, it seems likely that people who did not attend 
annual health check-up 10-years later might include those with severe illness, including CKD, 
and had begun regular medical examinations by a medical doctor between the baseline and 
the follow-up surveys. Our results may be affected by this sampling bias. Third, blood 
samples were not all obtained from participants under fasting conditions. We asked 
participants whether they had fasted or not at the interview, but misclassification may exist. 
However, we did examine the effect of diabetes on the risk for CKD and found that the effect 
was limited. Fourth, we defined CKD as eGFR <60 mL/min/1.73 m2 and/or proteinuria (2+ 
or 3+). According to KDIGO 2012, CKD includes kidney damage as albuminuria, urine 
sediment abnormalities, electrolyte and other abnormalities due to tubular disorders, 
abnormalities detected by histology, structural abnormalities detected by imaging, and history 
of kidney transplantation. We could not include these classifications because we did not have 
information about them. Fifth, we could not use information about cystatin-C because its 
measurement was not common between 1993 and 1996 in Japan. Therefore, the accuracy of 
eGFR in the fine categories is not guaranteed. Sixth, we developed calibration plots for each 
model. According to the plot, the reliability of the risk prediction equations was limited 
among people whose estimated risk was high. 
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In conclusion, we developed risk prediction equations for CKD at 10 years of 
follow-up among a Japanese general population. The validity of the risk prediction equations 
was high. These risk prediction equations may help physicians to identify individuals at high 
risk for CKD, particularly in Asian ethnic groups. 
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Table 1 Characteristics of Subjects Stratified by Sex and Area of Residence (Southern vs. Northern part of 
Ibaraki Prefecture, Japan) at Baseline 
 Men   Women 
 Northern 
region 
Southern 
region 
 Northern 
region 
Southern 
region 
N 17892 23110  40963 53042 
Cases of chronic kidney disease at 
10-years 
2840 3266  4660 5698 
Age (years) 58.5  56.8   55.0  54.3  
Body mass index (kg/m2) 23.4  23.5   23.4  23.4  
eGFR (ml/min/1.73m2) 87.9  89.3   95.1  96.9  
Dipstick Proteinuria (%)      
  + 1.4  1.2   0.5  0.8  
Missing 0.6  0.5   0.9  1.0  
Dipstick Hematuria (%)      
  + 3.5  6.3   7.1  10.9  
 2+ 1.4  2.9   4.1  6.8  
  3+ 0.9  0.9   2.4  2.6  
Missing 0.6  0.5   4.4  5.8  
Blood pressure levels      
Systolic blood pressure (mmHg) 134.3  134.2   129.2  129.4  
Diastolic blood pressure (mmHg) 80.3  81.1   76.9  77.4  
Medicated for hypertension (%) 16.9  16.6   14.2  14.2  
Glucose tolerance      
Fasting serum glucose (mg/dl)a 102.4  101.1   97.7  96.4  
Non-fasting serum glucose (mg/dl)b 118.4  118.3   108.0  107.9  
Medicated for diabetes mellitus 2.7  3.0   1.4  1.4  
Smoking (%)      
Past smoker 30.8  27.0   0.4  0.6  
Current smoker 44.4  49.1   3.9  5.0  
Alcohol intake (%)      
Occasional 14.0  13.1   6.4  7.3  
Everyday 53.9  58.1   3.8  4.8  
eGFR: estimated glomerular filtration rate at baseline     
a N=5952 in men living in northern region, N=9312 in men living in southern region, N=12715 in women living in 
northern region and N=21840 in women living in southern region  
b N=11940 in men living in northern region, N=13798 in men living in southern region, N=28248 in women living in 
northern region and N=31202 in women living in southern region 
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Table 2 Regression coefficients and odds ratios of Chronic Kidney Disease (stage 3 or higher and/or having 
proteinuria 2+ or 3+) among men Living in Northern Ibaraki Prefecture, Japan 
Model 1 (simple model)     
Risk factor Regression 
coefficient 
odds ratios 95 percent confidence 
intervals 
P value 
Intercept 3.3627  - - <0.001 
Age (years) 0.0404  1.041  1.035 - 1.048 <0.001 
eGFR (ml/min/1.73m2) -0.0932  0.911  0.907 - 0.915 <0.001 
Dipstick Proteinuria (%)     
   + 1.5395  4.662 3.412 - 6.369 <0.001 
Missing -0.1553  0.856  0.468 - 1.566 0.6  
Dipstick Hematuria (%)     
   + 0.4237  1.528  1.225 - 1.905 <0.001 
  2+ 0.2164  1.242  0.873 - 1.767 0.2  
   3+ 0.3232  1.382  0.892 - 2.141 0.1  
Missing - - - - 
     
Model 2 (full model)      
Risk factor Regression 
coefficient 
odds ratios 95 percent confidence 
intervals 
P value 
Intercept 1.7047  - - <0.001 
Age (years) 0.0402  1.041  1.034 - 1.048 <0.001 
eGFR (ml/min/1.73m2) -0.0928  0.911  0.907 - 0.915 <0.001 
Dipstick Proteinuria (%)     
   + 1.4492  4.260  3.183 - 5.990 <0.001 
Missing -0.1805  0.835  0.451 - 1.516 0.6  
Dipstick Hematuria (%)     
   + 0.4124  1.510  1.209 - 1.883 <0.001 
  2+ 0.1842  1.202  0.844 - 1.711 0.3  
   3+ 0.2892  1.335  0.854 - 2.057 0.2  
Missing - - - - 
Body Mass Index (kg/m2) 0.0323  1.033  1.016 - 1.050 <0.001 
Systolic blood pressure 
(mmHg) 
0.0077  1.008  1.005 - 1.011 <0.001 
Medicated for hypertension 0.2428  1.275  1.139 - 1.427 <0.001 
Glucose tolerance         
Fasting serum glucose 
(mg/dl) 
-0.0017  0.998  0.997 - 1.000 0.05  
Non-fasting serum glucose 
(mg/dl) 
-0.0016  0.998  0.997 - 1.000 0.02  
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Medicated for diabetes mellitus 0.2078 1.231 0.945 - 1.604 0.1 
Smoking status 
Past smoker -0.1581 0.854 0.756 - 0.964 0.01 
Current smoker 0.2313 1.260 1.123 - 1.415 <0.001 
Alcohol intake 
Occasional -0.0120 0.988 0.858 - 1.138 0.9 
Everyday -0.1639 0.849 0.767 - 0.939 0.002 
eGFR: estimated glomerular filtration rate at baseline 
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Table 3 Regression coefficients and odds ratios of Chronic Kidney Disease (stage 3 or higher and/or having 
proteinuria 2+ or 3+) among women Living in Northern Ibaraki Prefecture, Japan 
Model 1 (simple model) 
Risk factor Regression 
coefficient 
odds ratios 95 percent confidence 
intervals 
P value 
Intercept 3.0796 - - <0.001 
Age (years) 0.0309 1.031 1.027 - 1.036 <0.001 
eGFR (ml/min/1.73m2) -0.0816 0.922 0.919 - 0.924 <0.001 
Dipstick Proteinuria (%) 
   + 1.1677 3.214 2.289 - 4.515 <0.001 
Missing 0.1899 1.209 0.780 - 1.874 0.4 
Dipstick Hematuria (%) 
   + 0.0795 1.083 0.961 - 1.220 0.2 
  2+ 0.1349 1.144 0.982 - 1.333 0.08 
   3+ 0.4384 1.550 1.295 - 1.856 <0.001 
Missing 0.0884 1.092 0.846 - 1.411 0.5 
Model 2 (full model) 
Risk factor Regression 
coefficient 
odds ratios 95 percent confidence 
intervals 
P value 
Intercept 2.7879 - - <0.001 
Age (years) 0.0279 1.028 1.024 - 1.033 <0.001 
eGFR (ml/min/1.73m2) -0.0817 0.922 0.919 - 0.924 <0.001 
Dipstick Proteinuria (%) 
   + 1.1010 3.007 2.137 - 4.230 <0.001 
Missing 0.1601 1.174 0.756 - 1.822 0.5 
Dipstick Hematuria (%) 
   + 0.0907 1.095 0.971 - 1.234 0.1 
  2+ 0.1397 1.150 0.986 - 1.341 0.07 
   3+ 0.4574 1.580 1.319 - 1.893 <0.001 
Missing 0.0962 1.101 0.852 - 1.423 0.5 
Body Mass Index (kg/m2) 0.0067 1.007 0.995 - 1.018 0.2 
Systolic blood pressure 
(mmHg) 
0.0049 1.005 1.003 - 1.007 <0.001 
Medicated for hypertension 0.1029 1.108 1.015 - 1.210 0.02 
Glucose tolerance 
Fasting serum glucose 
(mg/dl) 
-0.0030 0.997 0.995 - 0.999 <0.001 
Non-fasting serum glucose 
(mg/dl) 
-0.0034 0.997 0.995 - 0.998 <0.001 
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Medicated for diabetes mellitus 0.6224 1.863 1.453 - 2.390 <0.001 
Smoking status 
Past smoker -0.1243 0.883 0.520 - 1.500 0.6 
Current smoker 0.3285 1.389 1.166 - 1.655 <0.001 
Alcohol intake 
Occasional -0.1964 0.822 0.706 - 0.957 0.01 
Everyday -0.1951 0.823 0.680 - 0.995 0.04 
eGFR: estimated glomerular filtration rate at baseline 
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Table 4  Predictive equations for chronic kidney disease at 10 years 
Risk for CKD at 10 years=1/1+exp(-(intercept + sum of the estimate per risk factors)) 
Model 1 (Simple model) 
 Men intercept + sum of the estimate per risk factors=3.3627 + 0.0404×age(years) -0.0932×eGFR(ml/min/1.73m2) 
+1.5395(if proteinuria(+)) + 0.4237(if hematuria(+))
Women intercept + sum of the estimate per risk factors=3.0796 + 0.0309×age(years) -0.0816×eGFR(ml/min/1.73m2) 
+1.1677(if proteinuria(+)) + 0.4384(if hematuria(3+))
Model 2 (Full modela) 
Men intercept + sum of the estimate per risk factors=1.7047 + 0.0402×age(years) -0.0928×eGFR(ml/min/1.73m2) 
+1.4492(if proteinuria(+)) + 0.4124(if hematuria(+))
+0.0323×BMI(kg/m2) + 0.0077×SBP(mmHg) + 0.2428 (if medicated for hypertension)
-0.0017×fasting serum glucose(mg/dl) -0.0016×non-fasting serum glucose(mg/dl) + 0.2078(if medicated for diabetes mellitus)
-0.1581(if past smoker) + 0.2313 (if current smoker) - 0.1639 (if daily drinker)
Women intercept + sum of the estimate per risk factors=2.7879 + 0.0279×age(years) -0.0817×eGFR(ml/min/1.73m2) 
+1.1010(if proteinuria(+)) + 0.4574(if hematuria(3+))
+ 0.0049×SBP(mmHg) + 0.1029 (if medicated for hypertension)
-0.0030×fasting serum glucose(mg/dl) -0.0034×non-fasting serum glucose(mg/dl) + 0.6224(if medicated for diabetes mellitus)
+0.3285 (if current smoker) - 0.1964(if occasional drinker) - 0.1951 (if daily drinker)
eGFR: estimated glomerular filtration rate at baseline 
BMI: body mass index 
SBP: systolic blood pressure 
a use fasting serum glucose or non-fasting serum glucose according to condition 
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Figure Legends 
Figure 1 Calibration plots of predictive equations for CKD risk at 10 years among men 
(A) Model 1, (B) Model 2. CKD, chronic kidney disease.
Figure 2 Calibration plots of predictive equations for CKD risk at 10 years among women 
(A) Model 1, (B) Model 2. CKD, chronic kidney disease.
Supplemental Table 1 How points were assigned
Risk Factors Regression coefficients P value
Regression
coefficients/constantA Points awardedB
Intercept -6.4049 <0.001
Age (years) 0.0536 <0.001
40-44C 0.00 0
45-49 1.00 1
50-54 2.00 2
55-59 3.00 3
60-64 4.00 4
65-69 5.00 5
70-74 6.00 6
eGFR (ml/min/1.73m2)
60-74 2.6370 <0.001 9.84 10
75-89 1.2163 <0.001 4.54 5
90-119 Reference 0
120- -1.3529 0.001 -5.05 -5
Dipstick proteinurea
+ 1.5038 <0.001 5.61 6
Missing -0.1391 0.6 - 0
Dipstick hematourea
+ 0.4126 <0.001 1.54 2
2+ 0.2231 0.2 - 0
3+ 0.3492 0.1 - 0
A constant = 0.0536 × 5 =0.268 (1 point was determined as the risk associated with a 5-year increase in age).
B Regression coefficients/constants were rounded to the nearest integer.
C People aged 40–44 were used for Reference.
Supplemental Table 3  Estimated risk for chronic kidney disease at 10 years stratified by sex
Risk Score (points)
Model 1 Model 2 Model 1 Model 2
-13 1%
-12 1%
-11 1%
-10 1%
-9 1%
-8 0% 1%
-7 0% 1% 1%
-6 0% 1% 1%
-5 0% 0% 1% 1%
-4 1% 1% 1% 1%
-3 1% 1% 2% 2%
-2 1% 1% 2% 2%
-1 1% 1% 2% 2%
0 2% 1% 2% 2%
1 2% 2% 2% 2%
2 3% 2% 3% 3%
3 3% 3% 3% 3%
4 4% 4% 4% 3%
5 6% 5% 4% 4%
6 7% 6% 4% 4%
7 9% 8% 5% 4%
8 12% 10% 6% 5%
9 15% 13% 6% 5%
10 19% 16% 7% 6%
11 23% 20% 8% 7%
12 28% 24% 9% 7%
13 34% 29% 10% 8%
14 40% 35% 11% 9%
15 47% 41% 12% 10%
16 53% 47% 13% 11%
17 60% 54% 15% 12%
18 66% 60% 17% 13%
19 72% 66% 18% 14%
20 77% 71% 20% 16%
21 81% 76% 22% 17%
22 85% 81% 24% 19%
23 88% 84% 27% 20%
24 91% 87% 29% 22%
25 90% 32% 24%
26 92% 34% 26%
27 94% 37% 28%
28 95% 40% 30%
29 43% 32%
30 46% 35%
31 49% 37%
32 52% 40%
33 55% 42%
34 58% 45%
35 61% 47%
36 64% 50%
37 66% 53%
38 69% 55%
39 72% 58%
40 74% 60%
41 76% 63%
42 78% 65%
43 68%
44 70%
45 72%
46 74%
47 76%
48 78%
49 80%
50 81%
51 83%
52 84%
53 86%
54 87%
55 88%
Men Women
Supplemental Table 2 Risk for chronic kidney disease at 10 years according to risk category stratified by sex
Points awarded for men Points awarded for women
Model 1 Age (years) 40-44 0 0
(simple model) 45-49 1 1
50-54 2 2
55-59 3 3
60-64 4 4
65-69 5 5
70-74 6 6
Dipstick Proteinuria + 6 10
Dipstick Hematuria + 2 0
2+ 0 0
3+ 0 4
eGFR (ml/min/1.73m2) 60-74 10 22
75-89 5 11
90-119 0 0
120- -5 -7
Model 2 Age (years) 40-44 0 0
(full model) 45-49 1 1
50-54 2 2
55-59 3 3
60-64 4 4
65-69 5 5
70-74 6 6
Dipstick Proteinuria + 6 11
Dipstick Hematuria + 2 0
2+ 0 0
3+ 0 4
eGFR (ml/min/1.73m2) 60-74 10 25
75-89 5 12
90-119 0 0
120- -5 -8
Blood pressure Stage 1 hypertensiona 1 1
Stage 2 hypertensionb 1 3
Stage 3 hypertensionc 3 0
Medicated for hypertension 2 2
Glucose tolerance Impaired glucose toleranced -1 -3
Diabetese 0 0
Medicated for diabetes 0 3
Smoking Past smoker -1 0
Current smoker 1 3
Alcohol intake Occasional 0 -2
Everyday -1 -2
eGFR: estimated glomerular filtration rate at baseline.
 a 140 mmHg ≤ systolic blood pressure < 160 mmHg and/or 90 mmHg ≤ diastolic blood pressure < 100 mmHg.
 b 160 mmHg ≤ systolic blood pressure < 180 mmHg and/or 100 mmHg ≤ diastolic blood pressure < 110 mmHg.
 c 180 mmHg ≤ systolic blood pressure and/or 110 mmHg ≤ diastolic blood pressure.
d 110 mg/dL ≤ fasting serum glucose < 126 mg/dL or 140 mg/dL ≤ non-fasting serum glucose < 200 mg/dL.
 e 126 mg/dL ≤ fasting serum glucose or 200 mg/dL ≤ non-fasting serum glucose.
P value P value
N
CKD event
Model 1 (simple model)
Age (years) 1.06 ( 1.05 - 1.06 ) <0.001 1.02 ( 1.02 - 1.03 ) <0.001
Dipstick proteinurea
+ 4.50 ( 3.31 - 6.12 ) <0.001 3.20 ( 2.29 - 4.46 ) <0.001
Missing 0.87 ( 0.48 - 1.59 ) 0.6 1.09 ( 0.70 - 1.68 ) 0.7
Dipstick hematourea
+ 1.51 ( 1.22 - 1.88 ) <0.001 1.08 ( 0.96 - 1.22 ) 0.2
2+ 1.25 ( 0.88 - 1.77 ) 0.2 1.13 ( 0.97 - 1.32 ) 0.1
3+ 1.42 ( 0.92 - 2.19 ) 0.1 1.55 ( 1.30 - 1.86 ) <0.001
Missing 1.31 ( 1.02 - 1.70 ) 0.04
eGFR (ml/min/1.73m2)
60-74 13.97 ( 12.18 - 16.03 ) <0.001 14.64 ( 13.17 - 16.26 ) <0.001
75-89 3.38 ( 2.92 - 3.90 ) <0.001 3.58 ( 3.21 - 3.99 ) <0.001
90-119
120- 0.26 ( 0.11 - 0.58 ) <0.001 0.43 ( 0.31 - 0.59 ) <0.001
Model 2 (full model)
Age (years) 1.05 ( 1.05 - 1.06 ) <0.001 1.02 ( 1.02 - 1.03 ) <0.001
Dipstick proteinurea
+ 4.34 ( 3.17 - 5.92 ) <0.001 3.12 ( 2.23 - 4.35 ) <0.001
Missing 0.87 ( 0.48 - 1.59 ) 0.7 1.05 ( 0.68 - 1.63 ) 0.8
Dipstick hematourea
+ 1.48 ( 1.19 - 1.85 ) <0.001 1.09 ( 0.97 - 1.23 ) 0.2
2+ 1.22 ( 0.86 - 1.73 ) 0.3 1.14 ( 0.98 - 1.33 ) 0.09
3+ 1.37 ( 0.88 - 2.12 ) 0.2 1.58 ( 1.32 - 1.88 ) <0.01
Missing 1.31 ( 1.01 - 1.69 ) 0.04
eGFR (ml/min/1.73m2)
60-74 14.05 ( 12.22 - 16.14 ) <0.001 14.61 ( 13.14 - 16.23 ) <0.001
75-89 3.42 ( 2.96 - 3.96 ) <0.001 3.58 ( 3.21 - 3.99 ) <0.001
90-119
120- 0.26 ( 0.12 - 0.59 ) 0.001 0.43 ( 0.31 - 0.58 ) <0.001
Blood pressure level
Stage 1 hype 1.24 ( 1.11 - 1.39 ) <0.001 1.11 ( 1.02 - 1.21 ) 0.02
Stage 2 hype 1.44 ( 1.18 - 1.75 ) <0.001 1.40 ( 1.18 - 1.66 ) <0.001
Stage 3 hype 1.95 ( 1.28 - 2.95 ) 0.002 0.83 ( 0.49 - 1.40 ) 0.5
Medicated for 1.62 ( 1.44 - 1.83 ) <0.001 1.25 ( 1.15 - 1.37 ) <0.001
Missing <0.01 ( <0.01 - >99.99 ) 0.9
Glucose tolerance
Impaired gluc 0.78 ( 0.68 - 0.89 ) <0.001 0.76 ( 0.67 - 0.86 ) <0.001
Diabetese 0.96 ( 0.77 - 1.18 ) 0.7 0.88 ( 0.70 - 1.10 ) 0.3
Medicated for 1.09 ( 0.85 - 1.40 ) 0.5 1.41 ( 1.12 - 1.77 ) <0.001
Missimg 0.40 ( 0.03 - 5.95 ) 0.5 0.69 ( 0.15 - 3.24 ) 0.6
Smoking status
Past smoker 0.88 ( 0.78 - 0.99 ) 0.03 0.91 ( 0.53 - 1.54 ) 0.7
Current smok 1.23 ( 1.09 - 1.37 ) <0.001 1.39 ( 1.17 - 1.66 ) <0.001
Alcohol intake
Occasional 0.99 ( 0.86 - 1.14 ) 0.9 0.83 ( 0.71 - 0.97 ) 0.02
Everyday 0.84 ( 0.76 - 0.92 ) <0.001 0.83 ( 0.69 - 1.00 ) 0.06
eGFR: estimated glomerular filtration rate at baseline.
 a 140 mmHg ≤ systolic blood pressure < 160 mmHg and/or 90 mmHg ≤ diastolic blood pressure < 100 mmHg.
 b 160 mmHg ≤ systolic blood pressure < 180 mmHg and/or 100 mmHg ≤ diastolic blood pressure < 110 mmHg.
 c 180 mmHg ≤ systolic blood pressure and/or 110 mmHg ≤ diastolic blood pressure.
 d 110 mg/dL ≤ fasting serum glucose < 126 mg/dL or 140 mg/dL ≤ non-fasting serum glucose < 200 mg/dL .
 e 126 mg/dL ≤ fasting serum glucose or 200 mg/dL ≤ non-fasting serum glucose.
-
-
Reference Reference
-
Reference Reference
Supplemental Table 4 Multivariable-adjusted odds ratios of chronic kidney disease (stage 3 or higher and/or proteinurea 2+ or 3+) among people living in the north of Ibaraki Prefecture, Japan
Men Women
17892 40963
2840 4660

． 
． ． ． 
◆
 
． 
◆
 
◆
 ． 
◆
 ◆
 
◆
 
� 
◆
 
0 OI
06 
ooo 
OL 
09 
os 
〇
寸
OE 
o
t
ol 
(o/o
) S;J!J!l!Q
B
Q
O
.ld
 p
aA
』asq
o
OOI 06 ooo OL 
（
苓
ァ
且
H
l!
Q
B
Q
0
[
 
d
 
p
a
p
!
p
;
u
d
 
0 9 05; Ot OE O
N
 
ol ゜゜
�
 
◆
 
． 
◄ � ＇ 
►�
◆
 
◆
 
�
 
• ． ◆
 
◆
 ． 
◆
 
ool 
06 
ooo 
OL 
09 
os 
o
v
 
0£ 
(o/o
) S:J!H
f!Q
B
Q
O
.ld
 p
aA.1
:JSQ
Q
 
O
N
 
OI
OOI 06 ooo OL 
（
苓
）
s
a
m
n
q
g
q
o
.1
d
 
p
a
J
;,
!
p
a
.1
d
 
0 9 0�Ov 0£ o
t
ol 。
゜
